Nuestros recursos

In three short years, decentralized clinical trials (DCTs) have turned skeptics into believers. Trial sponsors who were once hesitant are now embracing the DCT model—and for good reason. Today’s DCTs are addressing longstanding industry challenges, expanding access to patients and clinicians, increasing diversity, accelerating cohort recruitment, and improving retention.

When it comes to decentralized clinical trials (DCTs), the pharmaceutical industry finds itself at a crossroads.

Medical device trials are inherently challenging, particularly in women's health. But, within the context of a pandemic, the hurdles may seem insurmountable.

How Cutting-Edge Digital Instruments Can Optimize Data Collection and Improve Outcome Accuracy

Most of our prospective clients understand that virtual represents a new frontier in clinical research but often ask how to implement virtual solutions into their studies. Is this you? Maybe you already have a written protocol and want to gauge the possibility of a virtual transition, or perhaps you want first to determine the most effective trial design. Because these are scenarios we see so frequently, we thought we could offer a playbook to help you imagine your studies in a virtual way. Here are four big-ticket items that will impact how your study proceeds.